Disseminated Intravascular Coagulation Causes and Mechanisms

Primary Underlying Conditions

Sepsis is one of the most common causes of Disseminated Intravascular Coagulation (DIC), with significant endothelial dysfunction contributing to sepsis-induced coagulopathy, according to the Journal of Thrombosis and Haemostasis 1, 2
Various cancers, such as pancreatic cancer and adenocarcinomas, can trigger DIC, posing particularly high risks, as reported by the Journal of Thrombosis and Haemostasis 3
Acute liver failure can lead to DIC through multiple mechanisms, including decreased clearance of activated coagulation factors, as stated in the Journal of Thrombosis and Haemostasis 4

Endothelial injury is an essential component of DIC, in addition to systemic coagulation activation, according to the International Society on Thrombosis and Haemostasis (ISTH) 1, 5
Impaired anticoagulant mechanisms, including decreased levels of natural anticoagulants (protein C, protein S, antithrombin), contribute to uncontrolled coagulation, as reported by the Journal of Thrombosis and Haemostasis 2
Systemic inflammation triggers the coagulation cascade, particularly in sepsis, where endotoxin absorption leads to sustained inflammation, according to the Journal of Thrombosis and Haemostasis 4

Cancer-associated DIC can present in three forms: procoagulant DIC, hyperfibrinolytic DIC, and subclinical DIC, as reported by the Journal of Thrombosis and Haemostasis 3
Sepsis-induced DIC involves significant endothelial dysfunction, with high mortality (24.8% reported in a Japanese nationwide study), according to the Journal of Thrombosis and Haemostasis 1, 2
Liver disease-associated DIC involves multiple mechanisms, including activation of coagulation factors in the low-flow portal system, endotoxin absorption from intestines, and hepatocyte necrosis with tissue factor release, as stated in the Journal of Thrombosis and Haemostasis 4

The International Society on Thrombosis and Haemostasis (ISTH) recommends screening for sepsis-induced coagulopathy in patients with sepsis, as early detection of DIC is beneficial for predicting outcomes and managing critically ill patients 2
Understanding the specific mechanism of DIC is crucial for appropriate management, as treatment approaches differ based on whether the presentation is predominantly procoagulant, hyperfibrinolytic, or subclinical, according to the Journal of Thrombosis and Haemostasis 3

Malignancies are a major chronic trigger of DIC, with cancer‑associated DIC presenting in three patterns—procoagulant, hyper‑fibrinolytic, and a subclinical (chronic) form that persists with ongoing thrombin generation【6】.
Pancreatic adenocarcinomas and other adenocarcinomas carry a particularly high risk for chronic DIC【6】.
Metastatic prostate cancer and hematologic malignancies (e.g., acute leukemias) can precipitate chronic DIC【6】.
Vascular aneurysms induce chronic DIC through continuous low‑grade activation of coagulation within the aneurysm sac, leading to ongoing consumption of platelets and clotting factors【7】.

The subclinical chronic form is characterized by persistent laboratory abnormalities—moderate thrombocytopenia, reduced fibrinogen levels, and elevated D‑dimer—without overt bleeding or thrombotic symptoms【6】.

A mandatory prerequisite for diagnosing DIC is the identification of an underlying disorder that is known to be associated with DIC【8】.

Chronic liver disease (cirrhosis) should not be mistaken for chronic DIC; although laboratory profiles may resemble DIC, cirrhosis reflects a “rebalanced hemostasis” state unless a secondary trigger such as infection, bleeding, or shock is present【7】【9】【10】.

Graft rejection can precipitate acute DIC via rapid inflammatory tissue injury, illustrating the acute‑onset consumptive coagulopathy pattern distinct from chronic DIC【7】.